Interim Valeant CEO Schiller expects to stick to the script–and that means being ‘boring’ in 2016

Carly Helfand

When  installed former CFO Howard as CEO earlier this week, it said the board would continue to work closely with Schiller to implement company strategy in the absence of hospitalized chief J. Michael Pearson. But Schiller also has the authority to make big decisions on his own, should the need arise.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS